ReviewJournal of acquired immune deficiency syndromes (1999)2012
PEPFAR scale-up of pediatric HIV services: innovations, achievements, and challenges.
Review in Journal of acquired immune deficiency syndromes (1999), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Trial
- Age-Appropriateness of Oral Formulations Authorized for Pediatrics.Pharmaceutical research · 2026Article
- Characteristics of adolescents aged 15-19 years living with vertically and horizontally acquired HIV in Nampula, Mozambique.PloS one · 2021Article
- Article
- Article
- Uptake of care and treatment amongst a national cohort of HIV positive infants diagnosed at primary care level, South Africa.BMC infectious diseases · 2019Observational
- The gendered experience of HIV testing: factors associated with prior testing differ among men and women in rural Tanzania.International journal of STD & AIDS · 2019Article
- HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa.Journal of the International AIDS Society · 2018Article
- Inequality in outcomes for adolescents living with perinatally acquired HIV in sub-Saharan Africa: a Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Cohort Collaboration analysis.Journal of the International AIDS Society · 2018Article
- High risk of loss to follow-up among South African children on ART during transfer, a retrospective cohort analysis with community tracing.Journal of the International AIDS Society · 2017Article
- Active tracking of rejected dried blood samples in a large program in Nigeria.World journal of virology · 2016Article
- Massive benefits of antiretroviral therapy in Africa.The Journal of infectious diseases · 2014Article
- Article
- Beyond early infant diagnosis: case finding strategies for identification of HIV-infected infants and children.AIDS (London, England) · 2013Review
- Beyond prevention of mother-to-child transmission: keeping HIV-exposed and HIV-positive children healthy and alive.AIDS (London, England) · 2013Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
HIV/AIDS has had a profound impact on children around the world since the start of the epidemic. There are currently 3.4 million children under the age of 15 years living with HIV globally, and more than 450,000 children currently receiving lifesaving antiretroviral treatment. This article describes efforts supported by the President's Emergency Plan for AIDS Relief (PEPFAR) to expand access to treatment for children living with HIV in high-burden countries. The article also highlights a series of case studies that illustrate the impact that the PEPFAR initiative has had on the pediatric HIV epidemic. Through its support of host governments and partner organizations, the PEPFAR initiative has expanded HIV testing and treatment for pregnant women to reduce vertical transmission of HIV, increased access to early infant diagnosis for HIV-exposed infants, improved training and resources for clinicians who provide pediatric care and antiretroviral treatment, and, through public-private partnerships with pharmaceutical manufacturers, helped increase the number of medications available for the treatment of HIV-infected children in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.